Carbamazepine Rivo

Carbamazepine Rivo: a broad-spectrum anticonvulsant

Carbamazepine Rivo is an anticonvulsant that is used to treat various neurological diseases. The drug belongs to the group of iminostilbenes and is produced in Switzerland by the company Rivopharm SA.

Carbamazepine Rivo contains the active substance carbamazepine, which has anticonvulsant, antimanic and analgesic effects. The drug is available in the form of 200 mg tablets.

Indications for the use of Carbamazepine Rivo include the following conditions:

1. Epilepsy (except petit mal)
2. Manic states
3. Prevention of manic-depressive disorders
4. Alcohol withdrawal
5. Neuralgia of the trigeminal and glossopharyngeal nerves
6. Diabetic neuropathy

Contraindications to the use of Carbamazepine Rivo include hypersensitivity to the drug, atrioventricular block, a history of myelosuppression or acute porphyria, and pregnancy in the first trimester.

Carbamazepine Rivo may cause side effects, including dizziness, headache, hallucinations, agitation, depression, aggressive behavior, activation of psychosis, diplopia, accommodation disturbances, lens opacities, nystagmus, conjunctivitis, tinnitus, changes in taste, speech disorders, abnormal involuntary movements, peripheral neuritis, paresthesia, muscle weakness and symptoms of paresis, atrioventricular block, congestive heart failure, hyper- or hypotension, thromboembolism, increased levels of liver enzymes, jaundice, hepatitis, renal dysfunction, interstitial nephritis, nausea, vomiting, osteomalacia, sexual dysfunction functions, hyponatremia, moderate leukopenia, thrombocytopenia, hematopoietic disorders, multiorgan delayed-type hypersensitivity reactions, exfoliative dermatitis, lupus-like syndrome, Stevens-Johnson syndrome, Lyell syndrome, anaphylactic reactions.

When using Carbamazepine Rivo, possible interactions with other drugs must be taken into account. The drug is incompatible with MAO inhibitors, increases hepatotoxicity, isoniasis can reduce the effectiveness of contraceptives, and also increase the level of phenytoin and warfarin in the blood. In addition, Carbamazepine Rivo may interact with some antidepressants, antihistamines, anticoagulants, antibiotics, antifungals and other drugs.

The dosage of Carbamazepine Rivo should be individualized depending on age, weight, health status and therapeutic effect. Typically, the initial dose is 200-400 mg per day, which must be gradually increased to a therapeutic dose. The maximum dose of the drug is 1200 mg per day.

Overall, Carbamazepine Rivo is an effective anticonvulsant with a broad spectrum of action, however, like any other medicine, it can cause side effects and interact with other medicines. Therefore, before using Carbamazepine Rivo, you should consult your doctor and strictly follow his recommendations.